Kaplan Eytan, Weissbach Avichai, Kadmon Gili, Nahum Elhanan, Stein Jerry
Pediatric Intensive Care Unit, Petah Tikva, Israel.
Faculty of Medical Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
Transfusion. 2025 Jan;65(1):152-158. doi: 10.1111/trf.18075. Epub 2024 Nov 24.
Therapeutic plasma exchange (TPE) is a vital therapeutic modality in pediatric intensive care units (PICU) for various indications. Traditionally, pediatric TPE is performed via a large bore, double lumen catheter, whose insertion necessitates deep sedation, and poses risk of hemorrhagic and thrombotic complications. Building on our previous success utilizing percutaneous radial artery catheters (ALs) for apheresis procedures, we present our experience with ALs for TPE procedures in the PICU.
A retrospective cohort study, conducted in the PICU of a tertiary, university affiliated pediatric hospital, including all children aged 19 years and younger, who underwent TPE using an AL for vascular access, between 2018 and 2023. TPE procedures were evaluated for utility (the procedure was performed as planned) and safety.
A total of 72 procedures were performed on 20 children, using ALs for inlet access and peripheral intra-venous catheters for blood return. Procedure success rate was 94%, with AL malfunction causing transient delays in 6%. All were successfully completed following AL replacement. ALs were mostly 20 and 22 gauge, predominantly located in the radial artery. AL gauge did not significantly affect flow rate or procedure duration.
Our findings support AL use for vascular access, as a viable alternative to the traditional large bore, double lumen catheters most often used for TPE in children. Benefits of AL use may include a decrease in sedation requirements and a lower risk of vascular complications. Further investigation is warranted, for consideration as routine practice in PICUs.
治疗性血浆置换(TPE)是儿科重症监护病房(PICU)针对各种适应症的一种重要治疗方式。传统上,儿科TPE通过大口径双腔导管进行,其插入需要深度镇静,且存在出血和血栓形成并发症的风险。基于我们之前在使用经皮桡动脉导管(ALs)进行治疗性血液成分单采程序方面的成功经验,我们介绍我们在PICU中使用ALs进行TPE程序的经验。
在一所大学附属三级儿科医院的PICU进行了一项回顾性队列研究,纳入2018年至2023年间所有19岁及以下使用ALs作为血管通路进行TPE的儿童。对TPE程序的实用性(按计划进行该程序)和安全性进行评估。
共对20名儿童进行了72次程序,使用ALs作为进液通路,外周静脉导管作为回血通路。程序成功率为94%,6%的AL故障导致短暂延迟。更换AL后所有程序均成功完成。ALs大多为20号和22号,主要位于桡动脉。AL的规格对流速或程序持续时间没有显著影响。
我们的研究结果支持将ALs用于血管通路,作为儿童TPE最常用的传统大口径双腔导管的可行替代方案。使用ALs的好处可能包括镇静需求减少和血管并发症风险降低。有必要进行进一步研究,以考虑将其作为PICU的常规做法。